Cancer Trials: Patient-Reported Outcomes Should Measure Five Core Concepts, US FDA Says

 
• By Sue Sutter
Apple core
US FDA has suggested a set of core concepts on which it would like to see PRO data from cancer registrational trials. • Source: Alamy

More from Clinical Trials

More from R&D